The global Breast Cancer Market size was estimated at USD 31.89 Billion in 2022 and is projected to hit around USD 70.51 Billion by 2030 with a registered CAGR of 10.43% during the forecast period 2022 to 2030.

1. Contrive Datum Insights
Global Research And Consulting
A complete solution to explore all the potential aspect to
drive the growth of the business industries.

2. v
ABOUT US
Contrive Datum Insights (CDI) is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers. CDI’s experienced
team of Analysts, Researchers, and Consultants uses proprietary data sources and various
tools and techniques to gather, and analyse information. Our business offerings represent the
latest and the most reliable information indispensable for businesses to sustain a competitive
edge.
Each CDI syndicated research report covers a different sector — such as chemicals, materials,
metals & mining, pharmaceuticals, energy, automotive, food and beverages, semiconductors,
med-devices, consumer goods and information technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider scope and stratified
research methodology, our syndicated reports strive to serve the overall research requirement
of clients.

3. v
The global Breast Cancer Market size was estimated at USD 31.89 Billion in 2022 and is
projected to hit around USD 70.51 Billion by 2030 with a registered CAGR of 10.43% during
the forecast period 2022 to 2030.
Market Overview
Cancer of the breast is the most prevalent disease in the population. It primarily affects women,
and the incidence is increasing. Typically, breast cancer originates in the breast's tissues.
Symptoms of breast cancer include breast tumors, alterations in breast size and shape, fluid
leaking from the nipple, and itchy, scaly, red patches on the skin. It is a disease that is transmitted
by a disorder that exacerbates the symptoms, which include bone pain, swollen lymph nodes, and
difficulty inhaling, among others.Breast cancer can develop when genes like Human Epidermal
growth factor receptor 2 are present. (HER2). When this protein is present in the body, it
promotes the growth and multiplication of cancer cells. Patients with HER2 receptor positivity
have more aggressive breast cancer than other varieties.

4. v
Geographically, North America has the largest breast cancer market share and is the market leader. The market is
expanding because there are more treatments for breast cancer and more individuals are being diagnosed with the
disease. This is aided by the fact that the government is devoting more resources to the development of new
medicines, and the improved effectiveness and efficacy of medications also contributes to the expansion of the
market. There are more individuals in the market, and they are increasing their investments in new products,
thereby expanding the market. As the number of patients and their requirements increase, Asia-Pacific will have the
second largest market share. In Europe, Latin America, the Middle East, and Africa, the market is expanding.
Regional Analysis

5. v
The Global Breast Cancer Market has been segmented into:
By Therapy
• Targeted Therapy
• Hormonal Therapy
• Surgery and radiation therapy
• Biologic therapy
By Cancer Type
• Hormone Receptor
• HER2+
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

6. v
The Global Breast Cancer Market has been segmented into:
By Region
North America
• US
• Canada
• Mexico
• Rest of North America
The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
•Latin America
• Brazil
• Argentina
• Rest of Latin America
By Region
Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
By Region
Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe

7. v
• In September 2020, breast cancer market company Natco Pharma received FDA approval to begin
collaborating on Lapatinib Tablets, a product from marketing partner Lupin. NATCO was the first applicant for
Lapatinib Tablets. The same verified certificate was provided.
• In June 2020, Phesgo also received US federal approval to treat skin and related problems. Depending on the
diagnostic test, patients are selected for this test.
Strategic Developments

8. v
• Merck & Co
• Bristol Myers Squiib
• Kyowa Kirin
• Eisai Co.Ltd
• Sanofi
• Pfizer Inc
• AstraZeneca
• Novartis AG
• Eli Lilly and Company
• Genentech
• Mylan Laboratories
• Fresenius Kabi
• Baxter Healthcare Corporation
• Halozyme Inc
• GlaxoSmithKline
MARKET PLAYERS

9. v
CLIENTELE:
Some of the global leading clients that we have served:

10. v
CLIENTELE:
Some of the global leading clients that we have served:

11. v
Customer Experiences
“Very happy with the service. Report quality as well as response time
for my custom market study was great. I am looking forward to work
with Contrive Datum Insights (CDI) in future. “
G. Luca, A+ Outsourced Marketing
“We are satisfied with research report offered by Contrive Datum
Insights (CDI) .” We appreciate your support throughout the project.”
Consulting Company (privacy requested)
"You and your team did a terrific job on this project.” CDI will be at the
top of our list in the future for market research projects.”
Europe based Fortune 500 Company (privacy requested)

12. v
Benefits of
Association
By associating with Contrive Datum Insights (CDI) , customer can enjoy following
benefits:
 One-Stop-Destination for all research needs (Syndicate and Custom Reports)
 Reduced Budget and Faster Turnaround Time
 Focused Research Team - Contrive Datum Insights (CDI) can arrange a dedicated team of
2-3 resources with 1 Research Manager , who will look after any ad-hoc needs of the client
 Dedicated Account Manager
 24/7 availability for any custom needs of the client
 Flexible Partnering Model to accommodate client’s research needs
 Access to Data-Cuts related to required Market for global region
 ▪ Industry Update on Weekly/Bi-Weekly/Monthly basis
 ▪ Market Trend Analysis on Monthly/Quarterly basis

13. v
To know more about us, please visit our website:
www.contrivedatuminsights.com
For sales queries or new topics email us on:
anna@contrivedatuminsights.com
Thank You!